GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Policy Acquisition Expense

APLIF (Appili Therapeutics) Policy Acquisition Expense


View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Appili Therapeutics Business Description

Traded in Other Exchanges
Address
1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.